FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Jan. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Assets And Liabilities Measured On Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2024 were as follows:

 

			Fair Value Measurement at January 31, 2024 Using
	January 31, 2024		Quoted Prices  in Active  Markets for  Identical Assets  (Level 1)		Significant  Other  Observable  Inputs  (Level 2)		Significant  Unobservable  Inputs  (Level 3)
	(in millions)
Assets:
Short-term
Cash equivalents (money market funds)	$	1,102	$	1,102	$	—	$	—
Derivative instruments (foreign exchange contracts)	12		—		12		—
Long-term
Trading securities	38		38		—		—
Other investments	29		—		29		—
Total assets measured at fair value	$	1,181	$	1,140	$	41	$	—
Liabilities:
Short-term
Derivative instruments (foreign exchange contracts)	$	10	$	—	$	10	$	—
Contingent consideration	1		—		—		1
Long-term
Deferred compensation liability	38		—		38		—
Total liabilities measured at fair value	$	49	$	—	$	48	$	1

Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2023 were as follows:

			Fair Value Measurement at October 31, 2023 Using
	October 31, 2023		Quoted Prices  in Active  Markets for  Identical Assets  (Level 1)		Significant  Other  Observable  Inputs  (Level 2)		Significant  Unobservable  Inputs  (Level 3)
	(in millions)
Assets:
Short-term
Cash equivalents (money market funds)	$	994	$	994	$	—	$	—
Derivative instruments (foreign exchange contracts)	19		—		19		—
Long-term
Trading securities	36		36		—		—
Other investments	26		—		26		—
Total assets measured at fair value	$	1,075	$	1,030	$	45	$	—
Liabilities:
Short-term
Derivative instruments (foreign exchange contracts)	$	2	$	—	$	2	$	—
Contingent consideration	1		—		—		1
Long-term
Deferred compensation liability	36		—		36		—
Total liabilities measured at fair value	$	39	$	—	$	38	$	1

Gain (Loss) on Securities

Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:

	Three Months Ended
	January 31,
	2024		2023
	(in millions)
Net gain (loss) recognized during the period on equity securities	$	3	$	(10)
Less: Net gain (loss) on equity securities sold during the period	$	—	$	(11)
Unrealized gain (loss) on equity securities	$	3	$	1

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The contingent consideration liability is our only recurring Level 3 asset or liability. A summary of the Level 3 activity follows:

	Three Months Ended
	January 31,
	2024		2023
	(in millions)
Beginning balance	$	1	$	67
Additions to contingent consideration (including measurement period adjustment)	—		—
Payments	—		(65)
Change in fair value (included within selling, general and administrative expenses)	—		1
Ending balance	$	1	$	3